Dr Parmentier will present a poster “Combination Therapy in Melanoma: finding biomarkers of synergistic associations using Large Scale Drug Combination Screening and integrated Omics Data Analysis” at the Institut Pasteur International Network Scientific Symposium in Paris on November 30th.

 

poster117_thumbThe poster showcases the results of a collaborative study between Tersan and the Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

The 2016 edition of the symposium From basic science to biomarkers & tools in global health, which runs from November 29 to December 2nd, will also be attended by Dr Mohammad Afshar (CEO) and Dr Mariana Kuras (CTO).